⌘K

17:49:38·566d

13D/GFilingvia Quantisnow

Amendment: SEC Form SC 13G/A filed by Ocular Therapeutix Inc.

ByQuantisnow·Wall Street's wire, on your screen.

OCUL· Ocular Therapeutix Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Ocular Therapeutix™ to Host Investor Day on June 17, 2026
Officer Dugel Pravin received a gift of 394,696 shares, sold $173,479 worth of shares (21,156 units at $8.20) and gifted 394,696 shares, decreasing direct ownership by 0.81% to 2,597,170 units (SEC Form 4) to cover taxes
Chief Development Officer Kaiser Peter sold $24,329 worth of shares (2,967 units at $8.20), decreasing direct ownership by 1% to 266,141 units (SEC Form 4) to satisfy withholding obligation
Chief Scientific Officer Heier Jeffrey S. sold $24,748 worth of shares (3,018 units at $8.20), decreasing direct ownership by 0.93% to 320,350 units (SEC Form 4) to cover withholding tax
Chief Strategy Officer Nayak Sanjay sold $15,236 worth of shares (1,858 units at $8.20), decreasing direct ownership by 0.56% to 328,795 units (SEC Form 4) to satisfy withholding obligation